Aktiesnakken — Juni 2010
-
meget.. ville være rart at få afsluttet, men elv om Bp ikke får patentet, så er der jo heller ikke andre der har et patent, så FDA er eneste
-
så mangler vi bare 996 handler
-
forhindring de næste 5 år, hvis det er den tid det tager at få et patent igennem
-
nej diversification. Jeg må kun købe max 1000 til i genmab og det er stadig forbudte
-
spredning!
-
jeg forstår hende godt Hegu
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind